Researchers from EMD Serono and global collaborators shared promising results from Cohort B of the phase II trial of the WILLOW study.

This video shows what it means to eat healthy when you have lupus and offers advice on how to make healthy choices in your daily diet. Healthy eating can make a big difference in your lupus symptoms ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

Please upload 1-5 photos below. To help ensure consistency and quality, please keep the following guidelines in mind when taking or selecting a photo: Avoid visible brands or logos on shirts, hats and ...

This June, we recognize Men’s Health Month by honoring the strength, challenges and lived experiences of men with lupus.

Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage BCMAxCD3 bispecific T cell engager.

Lupus affects different people in different ways. Many people with lupus have problems with their liver. How does lupus affect the liver? Your liver helps your body digest food and filters waste out ...

Lupus can cause a lot of different skin problems, and there are many different kinds of medicines that can treat them. A special doctor called a dermatologist can help you find a treatment plan that ...

In this episode of the Lupus Foundation of America's The Expert Series podcast, we explore the intersection of menopause and lupus, highlighting the unique challenges faced by women with lupus during ...

AMPEL BioSolutions announced the launch of LuGENE®, an exciting breakthrough innovation in systematic lupus erythematosus (SLE) care. LuGENE® is a new blood test designed to predict SLE flares before ...

Today, the U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for Gazyva® (Obinutuzumab), for the potential treatment of lupus nephritis ...

Conduit Pharmaceuticals announced they will be conducting a Phase 2a clinical trial to evaluate AZD1656 for the treatment of multiple autoimmune diseases, including systemic lupus erythematosus (SLE), ...